Home
News
- 1 Johnson & Johnson (JNJ) stock price experiencing quite good trading volume with bulls dominance.
- 2 Last week, Johnson & Johnson released its Q2 2023 earnings and revenue report.
On July 20, 2023, Thursday, Johnson & Johnson (NYSE: JNJ) released its Q2 2023 earnings and revenue report. With a positive recent quarter report, JNJ stock price accumulated active bulls who drove its trading price above $174.00.
On its earnings day, the trading volume reached over 21 Million. Notably, this was the highest trading volume of JNJ stock in the last 5-months.
Amid similar (pharmaceutical: major) industry stocks, Pfizer Inc. (NYSE: PFE) stock price noted the highest trading volume of over 24 Million in the recent 1-day. SIGA Technologies Inc. (NASDAQ: SIGA) following Pfizer, indicating over 19 Million of volume. Johnson & Johnson further reserved its seat at third place with over 14 Million 1-day trading volume.
JNJ Stock Price Analysis
After the earnings report, JNJ stock price showed a 3.75% price rise in the weekly price analysis. However, near the weekend, JNJ shares added $2.98 and marked closing at $174.48 on July 28, 2023, Friday.
A pretty good trading volume activity was seen during this whole week where bulls have shown their potential strength.
The RSI of JNJ stock reached its overbought zone and continued its upside ride. It must be noted that from trading near its 100-day moving average, JNJ share price surpassed its 200-day moving average.
As per the recent trading day update, its share price is resting above the trading price of $174.00.
The 1-year price target set by analysts is showing at $183.83 which is up by 5.36% from the recent closing price of JNJ stock. The maximum price target set by the analysts is $215.00 whereas their minimum estimate is $165.00. In the past 3 months, analysts have given a “buy” rating to Johnson & Johnson stock.
Q2 2023 Highlights of Johnson & Johnson
According to the Q2 2023 earnings and revenue report of Johnson & Johnson (NYSE: JNJ), a pharmaceutical industry company, its net income is $5.14 Billion. Its earnings per share (EPS) in the quarter is $2.80 whereas the estimation was $2.62 which accounts for a 7.00% surprise.
The revenue for the same period amounts to $25.53 Billion despite the estimated figure of $24.63 Billion. For the next quarter, the estimated EPS is $2.67, and revenue is expected to reach $24.99 Billion.
The market cap of Johnson & Johnson is nearly $453.42 Billion. Meanwhile, its last year’s revenue amounted to $94.94 Billion, the most of which — $52.56 Billion— came from its highest performing source at the moment, Pharmaceutical.
Disclaimer
The views and opinions stated by the author, or any people named in this article, are for informational ideas only and do not establish financial, investment, or other advice. Investing in or trading crypto or stock comes with a risk of financial loss.
Andrew is a blockchain developer who developed his interest in cryptocurrencies while pursuing his post-graduation major in blockchain development. He is a keen observer of details and shares his passion for writing, along with coding. His backend knowledge about blockchain helps him give a unique perspective to his writing skills, and a reliable craft at explaining the concepts such as blockchain programming, languages and token minting. He also frequently shares technical details and performance indicators of ICOs and IDOs.
